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Summary
Objective: Classical neuronal signalling molecules such as substance P and glutamate have been identiﬁed in cartilage and have roles in
regulation of chondrocyte function. This study looks at expression and activity of the ionotropic glutamate NMDA (N-methyl-D-aspartic
acid) receptor (NMDAR) in human osteoarthritic (OA) chondrocytes.
Method: Chondrocytes were obtained from human knee joint arthroplasty specimens. NMDAR subunits and PSD-95 (postsynaptic density
protein 95) expression were analysed by reverse transcription-polymerase chain reaction and Western blotting. Activity of NMDAR was as-
sayed by radioactive calcium45 uptake and changes in membrane potential in the presence and absence of NMDA and NMDAR antagonists
and blockade of cell membrane ion channels.
Results: NMDAR 1, 2A, 2B and PSD-95 were detected in human OA chondrocytes whereas NR2B was absent from normal chondrocytes.
NMDA induced calcium ﬂux into OA chondrocytes and cell membrane depolarisation. These responses were blocked by NMDAR antagonists,
removal of extracellular calcium, inhibition of nNOS (neuronal nitric oxide synthase) activity and uncoupling of NMDAR from PSD-95. Blockade
of sodium channels by tetrodotoxin resulted in NMDA-induced membrane hyperpolarisation which was, in turn inhibited by apamin, a blocker
of SK channels. NMDA-induced changes in cell membrane potential were not affected by L-type and stretch activated calcium channel
inhibitors.
Conclusions: Human OA and normal articular chondrocytes differ in the expression of NMDAR subunits. In OA chondrocytes NMDAR
signalling requires extracellular calcium, association with PSD-95, and nNOS activity. Downstream signalling results in activation of tetrodo-
toxin sensitive sodium channels and SK channels, a response that differs from that of normal chondrocytes suggesting altered activity of
NMDAR in OA.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Articular cartilage is a highly specialised connective tissue
which provides a frictionless bearing surface while it also
functions to absorb and transmit compressive, tensile and
shear forces across diarthrodial joints. Mechanical forces
are required for maintenance of normal structure and func-
tion of articular cartilage but are also involved in the patho-
genesis of osteoarthritis. Chondrocytes, the sole cells within
cartilage recognise and respond to mechanical forces. It
appears likely that changes in the mechanical environment
as a result of alterations to the composition and organisa-
tion of the cartilage matrix or through excess or decreased*Address correspondence and reprint requests to: Dr Lindsay
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1576physical loading are perceived by articular chondrocytes
and modify cellular function leading to tissue remodelling.
In vitro studies have begun to provide insight into the
mechanotransduction process by which chondrocytes rec-
ognise a mechanical stimulus and transduce this stimulus
into a biochemical response. Integrins and stretch activated
ion channels (SAC) have been shown to be potential mech-
anoreceptors in human articular chondrocytes1. Mechanical
stimulation of monolayer cultures of human articular chon-
drocytes, results in activation of a5b1 integrin and SAC
with stimulation of downstream signal cascades that lead
to production of paracrine/autocrine signalling molecules
regulating chondrocyte responses. In normal articular chon-
drocytes (interleukin 4) appears to be the predominant
cytokine produced and is necessary for mechanical stimu-
lation induced upregulation of aggrecan gene expression2.
In contrast, chondrocytes from osteoarthritic (OA) cartilage
mechanically stimulated in an identical manner produce the
catabolic cytokine IL1b and do not show changes in
aggrecan gene expression.
A number of molecules traditionally identiﬁed and associ-
ated with neuronal and neuroepithelial cells are now
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creasing evidence that, at least some of, these molecules
may have important roles in regulation of chondrocyte func-
tion. N-CAM and n-cadherin are important in chondrogene-
sis and NG2/human melanoma proteoglycan (HMPG)
a chondroitin sulphate proteoglycan (CSPG) has been
shown to have roles in chondrocyte adhesion to type VI col-
lagen3. More recently human articular chondrocytes have
been shown to express preprotachykinin, substance P
and its receptor NK14 and NMDA receptors (NMDARs)5;
the latter being ligand gated ionotropic glutamate receptors
that mediate fast synaptic transmission in the central ner-
vous system. Roles for substance P and NMDAR in chon-
drocytes remain unclear but evidence is accumulating for
involvement in mechanotransduction.
The NMDAR receptor family is unique among ligand
gated ion channels in that it requires the binding of both glu-
tamate and a co-agonist, glycine, for its activation6. NMDAR
consists of three types of subunit; NR1, NR2 and NR3, with
NR2 and NR3 having several different subtypes (NR2AeD;
NR3AeB)7; For NMDAR to be functional both NR1 and
NR2 subunits are required, the functional NMDAR consist-
ing of a tetramer of NR1 and NR2 subunits8,9 although pen-
tamers associated with NR3 subunits have been found to
exist. NMDAR activation is enhanced by phosphorylation
events and the receptor is involved in a variety of signalling
cascades in neuronal cells. NMDAR is serine/threonine
phosphorylated by PKA, PKC and CaMKII and tyrosine
phosphorylated by Src and Fyn6. It is believed that the
NMDAR may regulate its own activity in association with
intracellular proteins. Intracellular proteins the NMDA recep-
tor is associated with include actin, ﬁlamentous proteins,
Src and CaMKII. Other signalling proteins are associated
with NMDA receptor through binding to PSD-95 which
acts as an anchor, clustering important signalling molecules
to the NMDA receptor10.
The current study was undertaken to extend further
analysis of NMDAR subunit expression in normal and OA
chondrocytes and to examine involvement of PSD-95 and
nNOS in NMDAR dependent signalling in OA chondrocytes.
In addition we aimed to assess whether NMDAR signalling
results in stimulation of either or both the SK channels and
tetrodotoxin sensitive sodium channels that are known to
be activated in chondrocytes in response to mechanical
loading.Materials and methods
All materials were obtained from SigmaeAldrich (Poole, UK) unless
otherwise stated.ISOLATION AND CULTURE OF CHONDROCYTESChondrocytes were isolated by sequential enzymatic digestion from car-
tilage obtained from human adult knee joints following knee replacement
surgery (OA) or resection for peripheral vascular disease (normal) with pa-
tient’s consent. Isolated cells were seeded in Iscove’s modiﬁed Dulbecco’s
medium supplemented with 10% foetal calf serum (ﬁrst link), 2 mM gluta-
mine, 100 IU/ml penicillin and 100 ug/ml streptomycin (both Invitrogen), at
5 104 cells/ml in 58 mm diameter tissue culture dishes (Nunc) unless
otherwise stated. Primary non-conﬂuent, non-passaged cultures of chondro-
cytes and freshly isolated OA cells (not cultured) were used as indicated in
experiments.REVERSE TRANSCRIPTION-POLYMERASE
CHAIN REACTION (RT-PCR)Total RNA was extracted from chondrocytes using a denaturing buffer of
4 M guanidine isothiocyanate, 0.75 M sodium citrate, 10% (w/v) laurylsarcosine and 7.2 ml/ml b-mercaptoethanol. The quantity of RNA in the sam-
ples was determined by absorbance readings at 260 nm on a spectrophotom-
eter (Genequant; Pharmacia). Template cDNA was synthesised using 0.5 mg
RNA, Superscript II (Invitrogen), and oligo dT (12e18; Amersham) according
to the manufacturers instructions. Exon speciﬁc primers used for the PCR
reaction were as follows:
A typical 20 ml PCR reaction contained 20 mM ammonium sulphate,
75 mM TriseHCl pH 8.8, 0.01% (v/v) Tween-20, 1 ml each primer, 2 ml
cDNA, 100 mM dNTPs, 0.1 (w/v) BSA (bovine serum albumin), 0.25 units
Taq polymerase (Biogene). The magnesium chloride concentrations used
were 2.5 mM GAPDH and 3 mM NMDAR. Samples were run for 3 min at
94C and then 35 cycles which consisted of denaturation at 94C for
1 min, annealing at 60C for 1 min and extension at 72C for 1.5 min, fol-
lowed by 10 min at 72C. PCR products were run on a 1% agarose gel
make up in SYBRsafe (Invitrogen). PCR products were visualised under
UV light using Versadoc (BioRad).PROTEIN EXTRACTION AND WESTERN BLOTTINGChondrocytes were washed with ice-cold PBS (phosphate buffered sa-
line) containing 100 mM Na3VO4 (Sigma) and lysed in situ with ice-cold lysis
buffer containing 1% Igepal (Sigma), 100 mM Na3VO4, and protease inhibitor
cocktail tablet (Roche) at 4C for 15 min. Supernatants were collected after
centrifugation at 13,000 rpm for 15 min. Whole cell extracts were separated
on a 6% SDS-PAGE under reducing conditions. Following electrophoresis
whole cell lysates were transferred onto polyvinylidene ﬂuoride (PVDF)
membranes (BDH). Membranes were blocked overnight at 4C with TBST
(tris buffered saline-Tween) Marvel (12.5 mM TriseHCl, pH 7.6, 137 mM
NaCl, 0.1% Tween-20, 5% Marvel). After washing with TBST, blots were in-
cubated for 1 h at room temperature with primary antibodies and then HRP
(horseradish peroxidase) labelled secondary antibodies. Membranes were
rewashed extensively and bands detected using Enhanced Chemilumines-
cense Plus (Amersham). Detection of NMDAR subunits was undertaken us-
ing goat anti-human antibodies (NR1, 2A, 2B; Santa Cruz) diluted 1/250,
loading control antibody used was a-tubulin (Abcam) diluted at 1/5000.CALCIUM ASSAYChondrocytes were seeded at a density of 2 104/ml in 24 well plates
(Nunc) and cultured for 1 week in media with 10% foetal calf serum. The
day before the experiment culture medium was replaced with serum free
media. Chondrocytes treated with 50 mM NMDA plus 20 mM glycine in the
absence or presence of NMDAR antagonists were incubated with
30e50 MBq/l Ca45 for 10 min at 37C, 5% CO2. After the 10 min incubation,
cells were washed once with fresh medium added with kynurenate (10 mM)
and magnesium (100 mM) prior to lysis with 1% Triton-X in PBS. After
1578 L. Ramage et al.: NMDAR expression in OA chondrocytesaddition of 1 ml of scintillation liquid (VWR), Ca2þ entry in count per minute
(cpm) was quantiﬁed using a Beckman LS6500 scintillation counter.ELECTROPHYSIOLOGICAL RECORDINGSMembrane potentials of chondrocytes were recorded using a single elec-
trode bridge circuit and calibrator as previously described in detail11. Micro-
electrodes having tip resistances between 40 and 60 mega ohms and tip
potentials of approximately 3 mV were used to impale the cells. Results
from a cell were accepted if on impalement there was a rapid change in
membrane voltage potential level in the cell and if this membrane potential
remained constant for at least 60 s. In each set of experiments, a control
dish of chondrocytes was examined whose culture medium did not contain
any agent to be tested. Resting membrane potentials of 5e10 cells were
measured and, following addition of the reagent to be tested to the culture
medium membrane potentials were assessed in a further 5e10 cells to
establish whether the reagent itself had an effect on the resting membrane
potential of the cells. Then, following a 10 min period of incubation with
50 mM NMDA plus 20 mM glycine membrane potentials were recorded in
a further 5e10 cells. At least three experiments with cells from three separate
donors were performed with each reagent.CHEMICAL REAGENTSThe following NMADR antagonists were used. MK801 (50 mM;
(5R,10S )-(þ)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine
hydrogen maleate dizocilpine hydrogen maleate) is a non-competitive
NMDAR inhibitor. APV (200 mM; D-2-amino-5-phosphonovaleric acid) is a com-
petitive blocker of NMDAR. Ifenprodil, 0.3 mM, selectively blocks NR2B con-
taining NMDAR. The TAT-NR2B9c peptide (5 mM) mimetic of NR2B-PDZ
ligand and uncouples NMDAR from nNOS production.
Other reagents used were tetrodotoxin (TTX; 1 mM) a selective sodium
channel blocker. Apamin (4.9 mM) was used to block SK channels (small
conductance Ca2þ dependant Kþ channels). To block L-type calcium
channel nifedipine (10 mM) was used whereas, gadolinium hexahydrate
(10 mM) was used to block stretch activated channels. EGTA (ethylene
glycol tetraacetic acid) (1.5 mM, 86 mM) was used to chelate extracellular
calcium and L-Nu-nitroarginine-2,4-L-diamino-butyric amide (L-Arg NO2-L-
Dbu-NH2 e 2TFA; 10 ng/ml, 100 ng/ml) was used as a highly selective
nNOS inhibitor.STATISTICAL ANALYSISAll experiments were repeated a minimum of three times each on different
days and as appropriate the mean and s.e.m. were calculated. The calcium
assay was performed in triplicate each day and the mean value for each was
designated n¼ 1. The values for electrophysiological recordings each day
were obtained from the mean of ﬁve recordings which are designated
n¼ 1. Statistical signiﬁcance was carried out using one-way analysis of var-
iance (ANOVA) and Tukey’s post hoc test for calcium assay and paired t test
for electrophysiological recordings. Differences were considered signiﬁcant
when P< 0.05.ResultsEXPRESSION OF NMDAR BY OA CHONDROCYTESNMDAR RNA was detected in both normal and OA chon-
drocytes (Fig. 1). Following RT-PCR, bands for NR1, 2A
and 2B were detectable in OA chondrocytes whereas
NR2C, 2D and NR3 were not identiﬁed. In contrast in nor-
mal chondrocytes NR1 and NR2A but not NR2B was
detected.
Western blotting of protein extracts from normal and OA
chondrocytes in short term monolayer cultures showed
expression of NMDAR NR2A (Fig. 2). NR2B was readily
detectable in OA chondrocytes but at best only a faint
band was seen in Western blots of protein extracted from
normal chondrocytes. NR1 protein was not detected in
extracts from either normal or OA chondrocytes. NR1,
NR2A and NR2B were each detected in protein extracts
from extracted, but not cultured, chondrocytes from OA car-
tilage. PSD-95, the major protein involved in anchoring
NMDAR to intracellular proteins was detectable by Western
blot in both normal and OA chondrocytes.OA CHONDROCYTES EXPRESS FUNCTIONAL NMDARTo establish whether chondrocytes expressed functional
NMDAR cells were incubated with 50 mM NMDA (in the
presence of 20 mM glycine) and either inﬂux of radioactive
Ca45 or changes in cell membrane potential were assessed.
Calcium45 uptake (Fig. 3)
NMDA (50 mM) with 20 mM glycine induced calcium
uptake by chondrocytes, with cpm of Ca45 in cell lysates
showing a signiﬁcant increase by 30e40% over cells at
rest. This NMDA-induced inﬂux of calcium into the chondro-
cytes was inhibited by the competitive antagonist APV
(200 mM) in separate experiments with chondrocytes from
three donors. The non-competitive NMDAR antagonist
MK801 (5 mM) also inhibited calcium ﬂux in NMDA treated
OA chondrocytes from three donors but in a fourth experi-
ment no signiﬁcant change was seen. There was a slight
but not statistically signiﬁcant increase in the calcium
uptake in chondrocytes following the addition of NMDAR
antagonists alone.
Changes in cell membrane potential (Fig. 4)
Addition of 50 mM NMDA with 20 mM glycine to normal
chondrocytes [Fig. 4(A)] for 10 min induced cell membrane
hyperpolarisation (P< 0.01). This response was inhibited
by the presence of MK801 or APV. In the presence of ifen-
prodil, an NMDAR antagonist that selectively inhibits recep-
tors containing the NR2B subunit, a signiﬁcant cell
membrane hyperpolarisation response to NMDA was seen.
Addition of 50 mM NMDA with 20 mM glycine to OA
chondrocytes [Fig. 4(B)] for 10 min resulted in a reproduc-
ible, highly signiﬁcant cell membrane depolarisation
(P< 0.001). MK801 alone induced a small but statistically
signiﬁcant membrane depolarisation in OA chondrocytes.
Addition of NMDA with glycine to MK801 treated cells, how-
ever, did not result in further membrane depolarisation.
APV had no effect on resting membrane potential of chon-
drocytes. Addition of NMDA with glycine to APV treated
cells induced a small but signiﬁcant (P< 0.05) cell mem-
brane hyperpolarisation. The NR2B selective antagonist,
ifenprodil (0.3 mM) when added to cells induced a small,
but, not statistically signiﬁcant membrane depolarisation.
Subsequent NMDA treatment resulted in a further cell
membrane depolarisation, but this did not reach statistical
signiﬁcance.SIGNALLING THROUGH NMDAR IN CHONDROCYTES
INVOLVES PSD-95 AND nNOSNMDAR signalling in neuronal cells involves amultimolec-
ular complex in which PSD-95 links NMDAR to nNOS. To
investigate whether this molecular complex plays a role in
NMDAR signalling in chondrocytes experiments were
undertaken with NR2B9c-TAT peptide (mimetic of NR2B-
PDZ ligand and uncouples NMDAR from nNOS production)
and L-Arg NO2-L-Dbu-NH2 e 2TFA a highly selective nNOS
inhibitor (Fig. 5). Treatment of chondrocytes with NR2B9c-
TAT inhibited the NMDA-induced membrane depolarisation
whereas control peptide had no effect (Fig. 6). The nNOS
inhibitor was used at two concentrations. At 100 ng/ml
L-Arg NO2-L-Dbu-NH2 e 2TFA completely inhibited the
membrane depolarisation response to NMDA whereas at
10 ng/ml the membrane depolarisation response was atten-
uated but membrane potentials of NMDA treated cells were
signiﬁcantly lower than untreated cells.
NR1 NR2A
NR2B NR2C
NR2D NR3
1 2 3 4 5 6 1 2 3 4 5 6
N OA +ve N OA +ve
Fig. 1. RT-PCR for NMDA receptors in unstimulated cells. Lanes 1, 3 and 5 are mRNA for NMDARs and, Lanes 2, 4 and 6 are GAPDH.
N – normal chondrocytes, OA – chondrocytes from patients with osteoathritis. Positive control used is rat brain cell lysate. Results shown
are representative from four patients.
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CHELATION ON THE ELECTROPHYSIOLOGICAL
RESPONSE OF OA CHONDROCYTES TO NMDAPrevious work from our group has suggested the NMDAR
may be involved in chondrocyte responses to mechanical
stimulation. Mechanical stimulation of OA chondrocytes is
calcium and SAC dependent and results in membrane de-
polarisation due to activation of a tetrodotoxin dependent
sodium channel. We assessed whether similar signalling
molecules and ion channels are involved the membrane
depolarisation induced in OA chondrocytes by NMDA.
EGTA blocked NMDA-induced depolarisation in a dose
dependent manner (Fig. 7). EGTA (1.5 mM) inhibitedα-tubulin α
αα-tubulin
1 2 3 4
1 2 3 4
NR1
NR2B
Fig. 2. Western blots for NMDA receptors and PSD-95 in unstimulated c
primary cell cultures. Positive control used is rat brain cell lysate (lane 3)
extraction from cartilage. Results shown amembrane depolarisation whereas a membrane depolarisa-
tion response was seen at lower the concentration of
86 mM. Treatment with nifedipine, to block L-type calcium
channels and gadolinium to block stretch activated ion
channels in contrast had no effect on NMDA-induced mem-
brane depolarisation (Fig. 8).
In the presence of tetrodotoxin, NMDA induced a mem-
brane hyperpolarisation response of 46% rather than mem-
brane depolarisation (Fig. 9). As we have previously shown
that membrane hyperpolarisation of human chondrocytes
may be the result of activation of SK channels we tested
apamin, a blocker of SK channels in the current system.
In the presence of apamin OA chondrocytes showed-tubulin
-tubulin
1 2 3 4
1 2 3 4
NR2A
PSD-95
ells. Lane 1 is normal and lane 2 is OA cell lysates obtained from
. Lane 4 is uncultured OA cells which were lysed immediately after
re representative from four patients.
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controls. However, when chondrocytes were treated with
apamin and tetrodotoxin together the change in membrane
potential (membrane depolarisation), with addition of
NMDA, was relatively small. Apamin and tetrodotoxin treat-
ment together resulted in a decrease in cell membraneA
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control cells (NMDA treated in the absence of the ion chan-
nel blockers).Discussion
This study investigates the expression of NMDAR in
human OA chondrocytes. We have previously reported pre-
liminary data on the expression of NMDAR subunits NR1
and NR2A in normal human articular chondrocytes and sug-
gested that NMDAR may have a role in chondrocyte
mechanotransduction5. The current work extends these
initial observations, characterising in detail, the NMDAR
subunits expressed in OA chondrocytes. Like normal chon-
drocytes OA chondrocytes express NR1 and NR2A but,
unlike normal chondrocytes, appear to additionally express
the NR2B subunit. By using assays of calcium uptake and
changes in cell membrane potential we have identiﬁed
involvement of PSD-95/nNOS in NMDAR signalling in OA
chondrocytes and identiﬁed activation of SK and tetrodo-
toxin sensitive ion channels as downstream responses.
In tissues which express NMDAR, several subtypes of
NR2 receptor co-exist. In neurones both NR1 and NR2 sub-
units are highly expressed. NMDARs are tetramers of two
NR1 and two NR2 subunits. The majority of neuronal
NMDAR are di-heteromeric and contain pairs of the same
subunit. There is evidence, however, of tri-heteromeric
receptors containing two different NR2 subunits. The forma-
tion of tetramers produces a functional receptor and theV APV +
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composition7. Functional NR1/NR2/NR3 tetrameric com-
plexes of receptors have also been identiﬁed in neurones12.
The present study demonstrates that OA chondrocytes
express NR1, NR2A and NR2B, and the scaffolding protein
PSD-95. This is a similar expression proﬁle to that of bone
cells13,14. NMDAR is, therefore, likely to exist as either di- or
tri-heteromeric tetramers but identiﬁcation of the exact com-
position of NMDAR in these cells is outwith the scope of the
current study. In cultured normal and OA chondrocytes we
could identify NR1 expression by RT-PCR but not by West-
ern blotting. As functional NMDAR requires NR1 and NR20
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observation that ifenprodil, a preferential NR1/NR2B antag-
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polarisation suggests that this electrophysiological
response of normal chondrocytes to NMDA is mediated
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a-amino-3-hydroxy-5-isoxazolepropionic acid (AMPA) glu-
tamate induced membrane depolarisation which leads to
relief of the voltage dependent channel block of NMDARs
by extracellular Mg2þ15. NMDARs are non-selective cation
channels permeable to Naþ and Kþ but also provide a signif-
icant inﬂux pathway for Ca2þ. This is accompanied by
release of glutamate from the stimulated cell propagating
the glutamate signal. The mechanism that links NMDA bind-
ing to channel gating is partly known and relies upon sub-
unit dimerisation16. Functional analysis of the NMDAR
receptor carried out in this study measured both calcium in-
ﬂux and changes in cell membrane potential. Stimulation of
OA chondrocyte NMDAR by NMDA in the presence of gly-
cine resulted in an increase in calcium inﬂux and membrane
depolarisation both of which were blocked by competitive
and non-competitive antagonists indicating the presence
of functional NMDAR. Activated NMDARs have a high per-
meability to calcium ions and inhibition of membrane depo-
larisation by EGTA demonstrates that extracellular calcium
is necessary for the response of chondrocytes in our sys-
tem to NMDA. NMDARs provide a signiﬁcant inﬂux pathway
for Ca2þ and the activity of these receptors is, as a conse-
quence, coupled to a variety of Ca2þ-dependent intracellu-
lar signalling pathways. Neither nifedipine sensitive L-type
ion channels nor gadolinium sensitive SAC channels ap-
pear to be involved in the production of the NMDA-induced
cell membrane depolarisation.
NMDARs are physically linked to a number of intracellular
signalling molecules including G proteins, Src, PYK, PKC,
calcium calmodulin dependent kinase through the scaffold
protein PSD-95. These signalling molecules in turn regulate
the activity of NMDAR6 whilst calcium inﬂux induces activa-
tion of downstream signalling through cascades involving
PI3K (phosphoinositide 3-kinase)eAkt, nNOS and MAPK
(mitogen-activated protein kinase)17,18. We have not dem-
onstrated a direct physical link between PSD-95 and
NMDAR in chondrocytes. The TAT-NR2B9c peptide (a mi-
metic of NR2B), which is known to dissociate the NMDAR
from PSD-95 preventing intracellular signalling via
nNOS19 inhibited NMDA-induced membrane depolarisationsupporting the idea that such linkage exists. Similarly inhibi-
tion of NMDA-induced membrane depolarisation by a selec-
tive nNOS inhibitor suggests that activation of OA
chondrocyte NMDAR requires nNOS activation. In the cur-
rent study the membrane potential of the chondrocytes is
measured 10 min after the application of NMDA and the
membrane depolarisation that is seen appears to be the re-
sult of downstream activation of tetrodotoxin dependent Na
channels. As such, the change in membrane potential is be-
ing used as a biological read-out of NMDA-induced effects
through NMDAR. The precise roles for nNOS in the
NMDAR dependent signalling cascade that results in acti-
vation of tetrodotoxin sensitive sodium channel induced
membrane depolarisation remains to be deﬁned.
In previous studies we have used changes in chondro-
cyte cell membrane potential as a highly sensitive and
reproducible bio-assay to study chondrocyte mechano-
transduction and identify mechanoreceptors and down-
stream signalling events. Mechanical stimulation of normal
human articular chondrocytes results in cell membrane
hyperpolarisation that is due to activation of apamin sensi-
tive SK channels (small conductance calcium sensitive
potassium channels) whereas similar mechanical stimula-
tion of OA chondrocytes results in a tetrodotoxin sensitive
cell membrane depolarisation indicating involvement of
sodium channels in the latter response2. We used tetrodo-
toxin in the current study to establish whether NMDA-
induced cell membrane depolarisation in OA cells was,
like mechanical stimulation induced membrane depolarisa-
tion, the result of activation of tetrodotoxin sensitive sodium
channels. These experiments unexpectedly resulted in the
unmasking of an NMDA-induced cell membrane hyperpo-
larisation. As a combination of apamin and tetrodotoxin
was necessary to block the electrophysiological responses
to NMDA it appears that both tetrodotoxin sensitive ion
channels and apamin sensitive SK channels are activated
downstream of NMDAR stimulation. Interestingly SK chan-
nels in neurones can be coupled to NMDARs and are
involved in feedback mechanisms20.
In neurones NMDAR may promote cell survival or when
excessively activated may stimulate cell death pathways.
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Fig. 8. Electrophysiological response of OA chondrocytes to 50 mM NMDA treatment in the presence and absence of 10 mM nifedipine and
10 mM gadolinium. Membrane potential in response to stimuli is measured in mV. Readings were taken in resting cells, after 10 min of treat-
ment with inhibitor, and after 10 min of NMDA stimulation. Asterisks indicate statistically signiﬁcant differences between resting and treated
cells, or identiﬁed cell treatments (***P< 0.001).
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but it is possible that functions will be similar to that of other
cells such as neurones. NMDAR signalling is likely to have
a variety of important functions in cartilage and depending
on whether signalling is physiological or pathological, main-
tains healthy cartilage or contributes to the pathological
changes in OA. Glutamate, the natural ligand for NMDAR
is increased in the synovial ﬂuid and presumably articular
cartilage in animal models of knee inﬂammation21 and
high concentrations of glutamate in synovial ﬂuid of patients
with active arthritis have been implicated in the pathological
process22. Interestingly high levels of glutamate/NMDA
result in neuronal cell death. Similar effects on chondrocyte
viability may contribute to increased apoptosis seen in the
cartilage of arthritic joints whether as a result of production
by chondrocytes themselves, possibly via mechanical load-
ing, or as a part of a more generalised inﬂammatory
response. Possible sources for glutamate release in arthritic0
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Fig. 9. Electrophysiological response of OA chondrocytes to 50 mM NMD
4.9 mM apamin. Membrane potential is measured in mV. Readings wer
after 10 min of NMDA stimulation. Asterisks indicate statistically signiﬁc
treatments (*P< 0.05joints would include afferent and sympathetic nerve termi-
nals, inﬂammatory cells or subarticular bone.
In conclusion this study categorises NMDAR subunit
expression in normal and OA chondrocytes, demonstrating
expression of NR2B in OA but not normal chondrocytes.
NMDAR function is dependent on association with PSD-
95 and nNOS and stimulation results in activation of ion
channels that we have previously identiﬁed as being acti-
vated in chondrocytes secondary to mechanical stimulation.
Preliminary studies from our group have suggested roles for
NMDAR in chondrocyte mechanotransduction but these
roles have yet to be deﬁned in detail. Chondrocyte
NMDARs are also likely to be activated by glutamate, pro-
duced from several potential sources, in the synovial ﬂuid
of joints developing arthritis and this may inﬂuence a variety
of cellular functions including survival. Whether these
receptors are involved in the regulation of anabolic and
catabolic activities that are required to maintain healthyApamin
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; ***P< 0.001).
1584 L. Ramage et al.: NMDAR expression in OA chondrocytescartilage or result in osteoarthritis is as unclear. The differen-
tial signalling by NR2B vs NR2A containing NMDARs with re-
gard to their differing roles in synaptic plasticity and cell
survival/death is an area of intense interest in neuroscien-
ce23e26. Our observations raise the possibility that NR2B vs
NR2A containing NMDARs may exert differing responses in
chondrocytes.Conﬂict of interest
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